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SUMMARY
Among 155 medical admissions to the intensive care 
unit during the period 1989 to 1990, 16 patients had 
Guillain-‘Barre’ Syndrome (GBS), five of whom ere 
HIV positive. Out of the five cases, three had 
manifested herpes zoster and one had TB. The impact 
of HIV infection o GBS is discussed.
INTRODUCTION
The global picture of tuberculosis (TB) appears to be 
changing dramatically for the worse as a result of the 
human immunodeficiency virus (HIV) pandemic, 
there is evidence that most of the increase in the 
number of TB cases attributable to HIV results from 
reactivation as cell-mediated immunity declines.1
further, HIV infection s related to immunological 
status. Guillain-'Barre’ Syndrome (GBS) is believed 
to have an immunological basis. Therefore, it is 
reasonable to suppose that in the presence of HIV 
infection, the course of GBS may be changed.
Out of a total of 155 medical patients admitted to 
the Intensive Care Units (ICUs) of the Harare Group 
of Teaching Hospitals (Harare and Parirenyatwa 
Teaching Hospitals), during a two-year period (1989 
to 1990), with respiratory failure, 16 (9,7 pc) had 
GBS. This study was performed to find out if there 
exists an association between HIV infection and 
GBS.
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MATERIALS AND METHODS
The case records of 16 patients admitted to ICU 
requiring mechanical ventilation for severe GBS 
were reviewed. The information was obtained from 
the patient’s notes and the ICU 24-hour chart 
The following information was extracted from the 
records: 1. Age; 2. Sex; 3. History of antecedent 
in fec tio n ; 4. D uration o f stay in ICU; 5. 
Complications; 6. HIV status; and 7. Outcome.
RESULTS
The ages of the patients ranged between 13 and 51 
years with a mean age of 31 years and standard 
deviation of 12,9. There was a predominance of 
females, 11 out of 16 as noted in Table I. Five (31 pc) 
of the patients were positive for HIV infection.
Table I: Age and Sex Distribution
Age Group No of Patients 
Male Female
10-19 Yrs 1 2
20-29 1 5
30-39 0 4
40-49 0 0
50-59 3 0
Total 5 11
Table IT. HIV Status
HIV Status
Antecedent Infection Positive Negative Not know
Herpes Zoster 3 
Tuberculosis 1 
Nil 1 B 3
Table III: Duration Of Stay in ICU
Duration No. of Patients 
Discharged Died
0 -2 0  days 2 3
2 1 -40  days 6 2
4 1 -60  days 0 0
6 1 -80  days 2 1
Average duration was 31 days.
Three (60 pc) of the five HIV positive patients had 
herpes zoster while one had TB prior to the onset of 
GBS (Table II). The m a jo r i ty  of the survivors (sixout
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of ten) spent between 21 to 40 days in the ICU (Table 
ID). The average stay in ICU (including the patients 
who died and those who were discharged) was 312 
days. Ten of the 16 patients were discharged from 
ICU, while six died, resulting in a mortality rate of 
—37,5 pc. Three of the patients who died developed 
cardiovascular complications, while one had 
tracheo-oesophageal fistula (Table IV).
Table TV: Complications and outcome
Complication Outcome No. of Patients/pc
Nil Discharged 10(62,5)
Cardiac arrhythmias Died 3
Tracheo oesophageal fistula Died 1 (37,5)
Not documented Died 1
DISCUSSION
Guillain ‘Barns’ Syndrome, also known as ascending 
polyneuritis or acute inflammatory demyelinating 
polyneuropathy, was described by Guillain, Barre 
and Strohl in 1916. However, the severe variant of the 
syndrome had been described by Landry in 1859.
In two thirds of the cases, an infectious episode, 
often an upper respiratory tract infection, usually 
precedes the onset of the neurologic syndrome by one 
to three weeks subsiding before the onset of the 
syndrome.2 GBS has also been reported to follow 
influenza vaccination, surgery and is thought to have 
an immunological basis. Osuntokun and Agbebi 
concluded that antecedent infection may play a major 
role in producing antigenic stimulation of antibody 
against nervous tissue.
The clinical criteria for this diagnosis of GBS 
include progressive motor weakness affecting at least 
two limbs and loss of reflexes.2 The muscle weakness 
usually starts in the legs, progresses upwards at a 
variable speed but reaches its peak before the fourth 
week. Milk sensory deficits may occur and cranial 
nerve involvement is sometimes seen. In all of the 
patients in this study, the diagnosis of GBS was made 
by the admitting physician before the patient was 
referred and admitted to ICU and the usual criteria 
were used.
In the series reported here, there of the five HIV 
positive patients had herpes zoster prior to the onset 
of GBS. In the light of this finding, it is fair to suggest 
that herpes zoster virus and HIV infection should be 
included in the group of viral infections associated 
with Guillain-Barre Syndrome. Prospective studies
involving larger series are required to confirm the 
association.
Perronne et al5 reported that in their series of 50 
patients with HIV infection, in 23 of them the testing 
had been prompted by the presence of herpes zoster.
Varicella in patients infected with HIV is more 
severe in its manifestation and often fatal.6 It is 
interesting to note that in our series two patients who 
died out of the five patients who had GBS and HIV 
infection had herpes zoster prior to the manifestation 
of the syndrome.
Clinical Course: GBS is a m onophasic 
polyneuropathy from which many patients ultimately 
recover satisfactorily.7 In the benign form of the 
disease, recovery is excellent and is complete in 80 
to 90 pc of patients while a small subset of patients 
have residual disability.2 Osuntokun and Agbebi 
concluded that the good prognosis makes it 
imperative to control respiration if bulbar or thoracic 
paralysis is present.4the severe end of the clinical 
spectrum of the Guillain ‘Barre’ Syndrome is 
characterised by nearly complete paralysis of somatic 
muscles including the respiratory muscles. All of the 
sixteen patients had the severe form of the syndrome. 
A decreasing vital capacity together with bulbar 
weakness, with difficulty in swallowing and 
coughing, is a dangerous combination leading to 
aspiration and acute respiratory failure. Artificial 
ventilation becomes necessary when the vital 
capacity shows a progressive decrease to less than 1 
litre of predicted value.8
The vital capacity was not determined in our 
patients prior to artificial ventilation. The decision to 
ventilate was made on clinical grounds and poor 
arterial blood gas results.
Second to respiratory failure, the commonest cause 
of death i GBS is cardiac arrhythmias.8 This was 
noted in three of the six patients who died. The 
arrhythm ias are frequently  associated with 
autonomic abnormalities. Demyelination of some of 
the fibres of the vagus may occur.9
Early in the disease, sinus tachycardia and 
persistent hypertension are frequently observed. 
Badycardia and hypotension are seen particularly 
following vagal stimulation from tracheal suction. 
The mechanism of death in a patient with excessive 
or paroxysmal autonomic activity is not well 
understood.
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It is possible that brain stem dysfunction is 
responsible for the abnormalities, that this leads to 
alterations in cardiac output or rhythm and thereby 
results in sudden death.1
The m ilestones of recovery are, return of 
respiratory muscle function and spontaneous 
breathing. A vital capacity greater than 1 to 1,5 litres 
is usually required before satisfactory spontaneous 
ventilation is achieved.
At this point, abdominal paradoxical movement 
disappears, signifying the return of adequate 
diaphragmatic activity. The sequence for weaning the 
patient from artificial ventilation is commenced 
guided by satisfactory arterial blood gas results.
In this series, ten of the sixteen patients recovered 
and were discharged from the ICU after an average 
stay of four and half weeks.
CONCLUSION
Out of 16 patients with GBS, three had herpes zoster 
and HIV infection. There appears to be evidence that 
HIV, in itself, is associated with GBS and TB and 
worsens the prognosis.
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